XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.2
STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Operating expenses:        
Research and development $ 211,752 $ 75,000 $ 475,511 $ 78,700
General and administrative 143,776 16,605 329,482 29,414
Total operating expenses 355,528 91,605 804,993 108,114
Operating loss (355,528) (91,605) (804,993) (108,114)
Other income (expense):        
Change in fair value of derivative liabilities 3,069,000   (867,000)  
Grant income 57,051   57,051  
Change in fair value of warrant liability 42,346   (4,769)  
Interest expense (41,966) (35,650) (94,736) (60,430)
Interest income 1 57 13 86
Total other income (expense), net 3,126,432 (35,593) (909,441) (60,344)
Income (loss) before income taxes 2,770,904 (127,198) (1,714,434) (168,458)
Income tax expense (benefit) 0 0    
Net income (loss) $ 2,770,904 $ (127,198) $ (1,714,434) $ (168,458)
Basic loss per common share $ 0.60 $ (0.03) $ (0.37) $ (0.04)
Diluted loss per common share $ 0.51 $ (0.03) $ (0.37) $ (0.04)
Weighted average number of common shares outstanding, basic 4,636,216 4,636,216 4,636,216 4,636,216
Weighted average number of common shares outstanding, diluted 5,400,184 4,636,216 4,636,216 4,636,216
Numerator        
Net income (loss) as adjusted $ 2,770,904 $ (127,198) $ (1,714,434) $ (168,458)